Literature DB >> 25726952

Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain.

Baptiste Lacoste1, Debora Angeloni, Sergio Dominguez-Lopez, Sara Calderoni, Alessandro Mauro, Franco Fraschini, Laurent Descarries, Gabriella Gobbi.   

Abstract

The involvement of melatonin in mammalian brain pathophysiology has received growing interest, but information about the anatomical distribution of its two G-protein-coupled receptors, MT1 and MT2 , remains elusive. In this study, using specific antibodies, we examined the precise distribution of both melatonin receptors immunoreactivity across the adult rat brain using light, confocal, and electron microscopy. Our results demonstrate a selective MT1 and MT2 localization on neuronal cell bodies and dendrites in numerous regions of the rat telencephalon, diencephalon, and mesencephalon. Confocal and ultrastructural examination confirmed the somatodendritic nature of MT1 and MT2 receptors, both being localized on neuronal membranes. Overall, striking differences were observed in the anatomical distribution pattern of MT1 and MT2 proteins, and the labeling often appeared complementary in regions displaying both receptors. Somadendrites labeled for MT1 were observed for instance in the retrosplenial cortex, the dentate gyrus of the hippocampus, the islands of Calleja, the medial habenula, the suprachiasmatic nucleus, the superior colliculus, the substantia nigra pars compacta, the dorsal raphe nucleus, and the pars tuberalis of the pituitary gland. Somadendrites endowed with MT2 receptors were mostly observed in the CA3 field of the hippocampus, the reticular thalamic nucleus, the supraoptic nucleus, the inferior colliculus, the substantia nigra pars reticulata, and the ventrolateral periaqueductal gray. Together, these data provide the first detailed neurocytological mapping of melatonin receptors in the adult rat brain, an essential prerequisite for a better understanding of melatonin distinct receptor function and neurophysiology.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  brain; immunohistochemistry; melatonin receptors; neuroanatomy; rat

Mesh:

Substances:

Year:  2015        PMID: 25726952     DOI: 10.1111/jpi.12224

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  39 in total

Review 1.  Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology.

Authors:  Md Farhad Hossain; Md Sahab Uddin; G M Sala Uddin; Dewan Md Sumsuzzman; Md Siddiqul Islam; George E Barreto; Bijo Mathew; Ghulam Md Ashraf
Journal:  Mol Neurobiol       Date:  2019-06-17       Impact factor: 5.590

Review 2.  Sleep, insomnia, and depression.

Authors:  Dieter Riemann; Lukas B Krone; Katharina Wulff; Christoph Nissen
Journal:  Neuropsychopharmacology       Date:  2019-05-09       Impact factor: 7.853

3.  Melatonin modulates daytime-dependent synaptic plasticity and learning efficiency.

Authors:  Antje Jilg; Philipp Bechstein; Anastasia Saade; Moritz Dick; Tian Xiao Li; Gianluca Tosini; Abdelhaq Rami; Ajmal Zemmar; Jörg H Stehle
Journal:  J Pineal Res       Date:  2019-02-14       Impact factor: 13.007

4.  Adrenal MT1 melatonin receptor expression is linked with seasonal variation in social behavior in male Siberian hamsters.

Authors:  Kathleen M Munley; Sohini Dutta; Aaron M Jasnow; Gregory E Demas
Journal:  Horm Behav       Date:  2021-12-15       Impact factor: 3.587

5.  Ramelteon Improves Post-traumatic Stress Disorder-Like Behaviors Exhibited by Fatty Acid-Binding Protein 3 Null Mice.

Authors:  Yasushi Yabuki; Ibuki Takahata; Kazuya Matsuo; Yuji Owada; Kohji Fukunaga
Journal:  Mol Neurobiol       Date:  2017-05-17       Impact factor: 5.590

Review 6.  Epigenetic regulation of melatonin receptors in neuropsychiatric disorders.

Authors:  Sarra G Bahna; Lennard P Niles
Journal:  Br J Pharmacol       Date:  2017-10-25       Impact factor: 8.739

7.  Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT1 receptor as well as BDNF expression in the hippocampus during the subjective light phase of rats exposed to chronic constant light.

Authors:  Jana Tchekalarova; Lidia Kortenska; Natasha Ivanova; Milena Atanasova; Pencho Marinov
Journal:  Psychopharmacology (Berl)       Date:  2019-11-13       Impact factor: 4.530

8.  Neuronal apoptosis can be prevented by the combined therapy with melatonin and hypothermia in a neonatal rat model of hypoxic-ischemic encephalopathy.

Authors:  Alina Mihaela Toader; Oana Hoteiuc; Cristina Bidian; Dan-Daniel Oltean; Flaviu Tabaran; Ovidiu Grad; Simona Clichici; Daniela Rodica Mitrea
Journal:  Med Pharm Rep       Date:  2021-04-29

9.  Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming.

Authors:  Chao Gu; Fen Wang; Yu-Ting Zhang; Shi-Zhuang Wei; Jun-Yi Liu; Hong-Yang Sun; Guang-Hui Wang; Chun-Feng Liu
Journal:  Aging Cell       Date:  2021-05-08       Impact factor: 9.304

10.  Pharmacological Actions of Carbamate Insecticides at Mammalian Melatonin Receptors.

Authors:  Grant C Glatfelter; Anthony J Jones; Rajendram V Rajnarayanan; Margarita L Dubocovich
Journal:  J Pharmacol Exp Ther       Date:  2020-11-17       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.